Diamens FlexCo

Based in Linz, Austria, Diamens FlexCo specializes in innovative diagnostic solutions targeting women's health, particularly through endometriosis detection using menstrual blood. Diamens FlexCo focuses on the development of diagnostic solutions for women's health. Founded in 2024, the company is headquartered in Linz, Austria. It has completed one investment deal as of March 25, 2026.

The founder's history remains unspecified. Diamens specializes in developing innovative diagnostic solutions for women’s health, focusing on endometriosis detection through menstrual blood. The company is creating the world's first home-based test that allows women to collect their menstrual blood samples conveniently and send them for analysis. This non-invasive approach aims to enhance accessibility to critical health information, specifically targeting women who may experience symptoms of endometriosis but have limited diagnostic options.

The test is designed to be affordable and user-friendly, catering to markets in Europe and North America, where awareness of women's health issues is increasing. Diamens' revenue model relies on direct-to-consumer sales of its diagnostic test kits. Customers will purchase a kit that facilitates self-sampling of menstrual blood, sending their samples to an accredited laboratory for analysis. The company plans to offer options for one-time purchases and subscription models for continuous testing.

Partnerships with healthcare providers and women’s health organizations will enhance market reach and service offerings. By prioritizing accessible pricing and streamlined purchasing, Diamens aims to establish a sustainable revenue stream while addressing the health needs of women worldwide. Diamens FlexCo plans to leverage its most recent funding round in March 2026, which involved a venture investment led by eQventure, to obtain certification for its molecular biological diagnostic test based on menstrual blood. The company aims to launch this innovative product in the near future while exploring expansion into additional markets, including broader regions in Europe and North America, to increase accessibility and awareness of its health solutions.